Skip to main navigation Skip to search Skip to main content

Osimertinib in patients with T790M mutation-positive, advanced non–small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies

  • Myung Ju Ahn
  • , Chun Ming Tsai
  • , Frances A. Shepherd
  • , Lyudmila Bazhenova
  • , Lecia V. Sequist
  • , Toyoaki Hida
  • , James C.H. Yang
  • , Suresh S. Ramalingam
  • , Tetsuya Mitsudomi
  • , Pasi A. Jänne
  • , Helen Mann
  • , Mireille Cantarini
  • , Glenwood Goss
  • Sungkyunkwan University
  • National Yang Ming Chiao Tung University
  • Princess Margaret Cancer Centre
  • University of California at San Diego
  • Massachusetts General Hospital
  • Aichi Cancer Center Hospital and Research Institute
  • National Taiwan University
  • Emory University
  • Kindai University
  • Dana-Farber Cancer Institute
  • AstraZeneca
  • University of Ottawa

Research output: Contribution to journal › Article › peer-review

150   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Osimertinib in patients with T790M mutation-positive, advanced non–small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science